LEDS

SemiLEDs Corp

Nasdaq · Semiconductors & Related Devices · CIK 0001333822
$1.90 +4.40% $15.7M
High Impact Filing (7/10)
Vol
Market Cap$15.7M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$130.3K
Inst. Activity1 buys / 0 sells
SEC Reports1
Exchange Nasdaq·Sector Semiconductors & Related Devices·CIK 0001333822·Prev Close $1.82

Recent Activity

Apr 14, 2026 SEC
SemiLEDs reported Q2 FY2026 revenue of $1.1 million, down from $2.6 million in Q1, with a net loss of $603K and EPS of $
8-K — Impact 7/10
Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
57,413 shares ($125.7K)
Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
34,100 shares ($89.3K)

Analyst Ratings

Historical Analyst Actions
DateFirmActionRating
Nov 29, 2012 Sterne Agee MAINTAIN Buy
Nov 28, 2012 Caris & Co. DOWNGRADE Buy → Above Average
Nov 26, 2012 Caris & Co. DOWNGRADE Buy → Above Average
Jul 11, 2012 Sterne Agee MAINTAIN Buy
Jul 10, 2012 Canaccord Genuity MAINTAIN Hold

Top Institutional Holders

FundValueMove
RENAISSANCE TECHNOLOGIES LLC$77.1KADD
CITADEL ADVISORS LLC$27.5K
SUSQUEHANNA INTERNATIONAL GROUP, LLP$25.7K
3 institutional holders with $130.3K total value (104,200 shares) as of 2026-Q1. Top holders: RENAISSANCE, CITADEL, SUSQUEHANNA.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1RENAISSANCE TECHNOLOGIES LLC61,700$77.1K59.2%ADD +68.4%
2CITADEL ADVISORS LLC21,969$27.5K21.1%
3SUSQUEHANNA INTERNATIONAL GROUP, LLP20,531$25.7K19.7%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
RENAISSANCE TECHNOLOGIES LLCADD34,10057,413+68.4%$125.7K2025-Q3
RENAISSANCE TECHNOLOGIES LLCDOUBLED15,90034,100+114.5%$89.3K2025-Q2
RENAISSANCE TECHNOLOGIES LLCTRIM39,71615,900-60.0%$35.5K2025-Q1
UBS Group AGNEAR_EXIT4,157841-79.8%$1.9K2025-Q1
RENAISSANCE TECHNOLOGIES LLCDOUBLED12,70039,716+212.7%$51.2K2024-Q4

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2014-08-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
4 analyst firms have rated this stock: 0 upgrades, 2 downgrades, 0 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Nov 29, 2012 Sterne Agee MAINTAIN Buy
Nov 28, 2012 Caris & Co. DOWNGRADE Buy Above Average
Nov 26, 2012 Caris & Co. DOWNGRADE Buy Above Average
Jul 11, 2012 Sterne Agee MAINTAIN Buy
Jul 10, 2012 Canaccord Genuity MAINTAIN Hold
Jul 10, 2012 Jefferies MAINTAIN Hold

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.